Cargando…

Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring

BACKGROUND: Results of some studies suggest that prenatal antidepressant exposure increases the risk of autism spectrum disorder (ASD) in offspring, while other studies suggest that depression independently increases the risk of having a child with ASD. Thus, confounding by indication is a concern....

Descripción completa

Detalles Bibliográficos
Autores principales: Hagberg, Katrina Wilcox, Robijn, Annelies L, Jick, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219268/
https://www.ncbi.nlm.nih.gov/pubmed/30464639
http://dx.doi.org/10.2147/CLEP.S180618
_version_ 1783368622526169088
author Hagberg, Katrina Wilcox
Robijn, Annelies L
Jick, Susan
author_facet Hagberg, Katrina Wilcox
Robijn, Annelies L
Jick, Susan
author_sort Hagberg, Katrina Wilcox
collection PubMed
description BACKGROUND: Results of some studies suggest that prenatal antidepressant exposure increases the risk of autism spectrum disorder (ASD) in offspring, while other studies suggest that depression independently increases the risk of having a child with ASD. Thus, confounding by indication is a concern. OBJECTIVE: The aim of this study was to estimate the risk of ASD in offspring of women who were exposed to antidepressants and/or had depression during pregnancy compared to unexposed women. MATERIALS AND METHODS: We conducted a cohort study with nested sibling case–control analysis. Using the UK Clinical Practice Research Datalink (CPRD), we identified mother– baby pairs where the mother had ≥12 months of history before the delivery date and the child had ≥3 years of follow-up. Exposures during pregnancy were classified as 1) depression treated with antidepressants, 2) untreated depression, 3) other indications for antidepressant use, and 4) 4:1 match of unexposed women with no history of depression or antidepressant use. We calculated the prevalence of ASD and relative risk (RR) with 95% CI. In the sibling analysis, we compared exposure among ASD cases to that of non-ASD siblings born to the same mother. We calculated ORs and 95% CIs for women with treated and untreated depression, compared to unexposed. RESULTS: We identified 2,154 offspring with ASD among 194,494 mother–baby pairs. Compared to unexposed, the RR of ASD was 1.72 (95% CI 1.54–1.93) for treated depression and 1.50 (95% CI 1.28–1.75) for untreated depression, while the RR was not elevated in women who received antidepressants for other indications (RR =0.73, 95% CI 0.41–1.29). Additional analyses to assess the effects of severity of depression suggest that the risk of ASD in offspring increases with increasing severity, not with the antidepressant treatment. The results of the sibling analysis were similar to the main analysis. CONCLUSION: Women with depression during pregnancy have an increased risk of having a child with ASD, regardless of antidepressant use.
format Online
Article
Text
id pubmed-6219268
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62192682018-11-21 Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring Hagberg, Katrina Wilcox Robijn, Annelies L Jick, Susan Clin Epidemiol Original Research BACKGROUND: Results of some studies suggest that prenatal antidepressant exposure increases the risk of autism spectrum disorder (ASD) in offspring, while other studies suggest that depression independently increases the risk of having a child with ASD. Thus, confounding by indication is a concern. OBJECTIVE: The aim of this study was to estimate the risk of ASD in offspring of women who were exposed to antidepressants and/or had depression during pregnancy compared to unexposed women. MATERIALS AND METHODS: We conducted a cohort study with nested sibling case–control analysis. Using the UK Clinical Practice Research Datalink (CPRD), we identified mother– baby pairs where the mother had ≥12 months of history before the delivery date and the child had ≥3 years of follow-up. Exposures during pregnancy were classified as 1) depression treated with antidepressants, 2) untreated depression, 3) other indications for antidepressant use, and 4) 4:1 match of unexposed women with no history of depression or antidepressant use. We calculated the prevalence of ASD and relative risk (RR) with 95% CI. In the sibling analysis, we compared exposure among ASD cases to that of non-ASD siblings born to the same mother. We calculated ORs and 95% CIs for women with treated and untreated depression, compared to unexposed. RESULTS: We identified 2,154 offspring with ASD among 194,494 mother–baby pairs. Compared to unexposed, the RR of ASD was 1.72 (95% CI 1.54–1.93) for treated depression and 1.50 (95% CI 1.28–1.75) for untreated depression, while the RR was not elevated in women who received antidepressants for other indications (RR =0.73, 95% CI 0.41–1.29). Additional analyses to assess the effects of severity of depression suggest that the risk of ASD in offspring increases with increasing severity, not with the antidepressant treatment. The results of the sibling analysis were similar to the main analysis. CONCLUSION: Women with depression during pregnancy have an increased risk of having a child with ASD, regardless of antidepressant use. Dove Medical Press 2018-11-01 /pmc/articles/PMC6219268/ /pubmed/30464639 http://dx.doi.org/10.2147/CLEP.S180618 Text en © 2018 Hagberg et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Hagberg, Katrina Wilcox
Robijn, Annelies L
Jick, Susan
Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring
title Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring
title_full Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring
title_fullStr Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring
title_full_unstemmed Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring
title_short Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring
title_sort maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219268/
https://www.ncbi.nlm.nih.gov/pubmed/30464639
http://dx.doi.org/10.2147/CLEP.S180618
work_keys_str_mv AT hagbergkatrinawilcox maternaldepressionandantidepressantuseduringpregnancyandtheriskofautismspectrumdisorderinoffspring
AT robijnanneliesl maternaldepressionandantidepressantuseduringpregnancyandtheriskofautismspectrumdisorderinoffspring
AT jicksusan maternaldepressionandantidepressantuseduringpregnancyandtheriskofautismspectrumdisorderinoffspring